<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Overview of benign lesions of the skin
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Overview of benign lesions of the skin
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Overview of benign lesions of the skin
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Adam O Goldstein, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert P Dellavalle, MD, PhD, MSPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rosamaria Corona, MD, DSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 13, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Individuals may acquire a multitude of benign skin lesions over the course of a lifetime. Many of these lesions are easily visible, and patients often ask clinicians to confirm that new growths on the skin are benign.
        </p>
        <p>
         The clinical features, diagnosis, and treatment of some acquired benign skin lesions will be discussed here. Benign lesions in the newborn and infant are discussed separately. Malignant neoplasms of the skin are also discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/119230.html" rel="external">
          "Skin lesions in the newborn and infant"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5335.html" rel="external">
          "Basal cell carcinoma: Epidemiology, pathogenesis, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/16225.html" rel="external">
          "Cutaneous squamous cell carcinoma (cSCC): Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15806.html" rel="external">
          "Melanoma: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H396559868">
         <span class="h1">
          APPROACH TO DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most benign skin lesions are diagnosed based on clinical appearance (morphology, distribution) and history. (See
         <a class="medical medical_review" href="/z/d/html/6838.html" rel="external">
          "Approach to the clinical dermatologic diagnosis"
         </a>
         .)
        </p>
        <p>
         Dermoscopy, a skin examination technique performed with a handheld instrument called a dermatoscope that allows the visualization of subsurface skin structures, is a helpful adjunct to the clinical examination of a variety of pigmented and nonpigmented lesions. (See
         <a class="medical medical_review" href="/z/d/html/13522.html" rel="external">
          "Dermoscopic evaluation of skin lesions"
         </a>
         .)
        </p>
        <p>
         If the diagnosis of a lesion is uncertain or if a lesion has exhibited unexpected or rapid changes in appearance or symptoms, a diagnostic procedure (eg, biopsy, excision) is indicated for a precise diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/5577.html" rel="external">
          "Skin biopsy techniques"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1101419748">
         <span class="h1">
          DERMAL TUMORS
         </span>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h2">
          Acrochordon (skin tag)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acrochordons, commonly known as skin tags or fibroepithelial polyps, are benign outgrowths of normal skin. They usually appear as pink, red, or white pedunculated lesions on a narrow stalk  (
         <a class="graphic graphic_picture graphicRef53025 graphicRef70871 graphicRef78524 graphicRef78625 graphicRef58450" href="/z/d/graphic/53025.html" rel="external">
          picture 1A-E
         </a>
         ).
        </p>
        <p>
         Acrochordons are common in adult individuals, and the risk of developing them increases with age [
         <a href="#rid1">
          1
         </a>
         ]. They are frequently seen in patients who are obese and in patients with diabetes mellitus [
         <a href="#rid2">
          2,3
         </a>
         ]. Observational studies suggest that acrochordons may be a skin sign of insulin resistance and metabolic syndrome [
         <a href="#rid4">
          4-6
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/1762.html" rel="external">
          "Insulin resistance: Definition and clinical spectrum"
         </a>
         ). Skin tags also appear with increased frequency during the second trimester of pregnancy and may regress postpartum [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         Acrochordons usually occur in sites of friction, particularly the axilla, neck, inframammary, and inguinal regions. They become symptomatic and bothersome for many patients when traumatized (eg, caught on jewelry, rubbed by clothing, itching). An infarcted acrochordon, resulting from torsion of its peduncle, appears as a red or black lesion  (
         <a class="graphic graphic_picture graphicRef65856" href="/z/d/graphic/65856.html" rel="external">
          picture 1F
         </a>
         ).
        </p>
        <p>
         Perianal skin tags are common in patients with Crohn disease [
         <a href="#rid8">
          8
         </a>
         ]. Acrochordons, together with fibrofolliculomas and trichodiscomas, are seen in Birt-Hogg-Dubé syndrome, an inherited condition characterized by cutaneous adnexal tumors, lung cysts, spontaneous pneumothorax, and increased risk of kidney cancer [
         <a href="#rid9">
          9
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/4082.html" rel="external">
          "Perianal Crohn disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/100661.html" rel="external">
          "Birt-Hogg-Dubé syndrome"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of acrochordons is usually based upon clinical appearance. They must be differentiated from neurofibromas, which are usually larger and firmer than acrochordons  (
         <a class="graphic graphic_picture graphicRef82612" href="/z/d/graphic/82612.html" rel="external">
          picture 2
         </a>
         ), and from pedunculated dermal nevus  (
         <a class="graphic graphic_picture graphicRef76961" href="/z/d/graphic/76961.html" rel="external">
          picture 3
         </a>
         ). The latter sometimes can only be differentiated histologically. (See
         <a class="medical medical_review" href="/z/d/html/2939.html" rel="external">
          "Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis", section on 'Peripheral neurofibromas'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – Treatment is indicated if lesions are irritating or the patient desires removal for cosmetic reasons. Local anesthesia with 1%
         <a class="drug drug_general" data-topicid="9559" href="/z/d/drug information/9559.html" rel="external">
          lidocaine-epinephrine
         </a>
         may be required in larger lesions to lessen bleeding and lower discomfort on removal. Treatment options include (see
         <a class="medical medical_review" href="/z/d/html/5562.html" rel="external">
          "Office-based dermatologic diagnostic procedures"
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Removal with snip excision with forceps and fine-grade scissors or with shave excision; larger lesions may require suturing.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cryosurgery with liquid nitrogen directly to lesions or with forceps is an effective way to treat multiple skin tags [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Electrodesiccation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Larger lesions often bleed freely after surgical removal. Thus, aluminum chloride,
         <a class="drug drug_general" data-topicid="9888" href="/z/d/drug information/9888.html" rel="external">
          silver nitrate
         </a>
         sticks, or electrosurgery should be readily available for coagulation; however, silver nitrate may cause permanent skin pigmentation [
         <a href="#rid11">
          11
         </a>
         ]. Lesions are unlikely to recur after removal, but new lesions develop in predisposed skin areas.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Counseling patients with multiple acrochordons about obesity, prediabetes, and diabetes risks is also appropriate.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1101419831">
         <span class="h2">
          Dermatofibroma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dermatofibroma, also called benign fibrous histiocytoma, is one of the most common cutaneous soft-tissue lesions. It represents a benign dermal proliferation of fibroblasts. The pathogenesis, clinical presentation, diagnosis, and management of dermatofibroma are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/142252.html" rel="external">
          "Dermatofibroma (benign fibrous histiocytoma)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3859593490">
         <span class="h2">
          Cutaneous neurofibroma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cutaneous neurofibroma is a benign nerve sheath tumor composed of cells of neuromesenchymal origin, including Schwann cells, fibroblasts, perineurial cells, and mast cells. (See
         <a class="medical medical_review" href="/z/d/html/15269.html" rel="external">
          "Peripheral nerve tumors", section on 'Neurofibroma'
         </a>
         .)
        </p>
        <p>
         Multiple cutaneous neurofibromas and their variants (ie, plexiform, dermal) occur in the setting of neurofibromatosis type 1. (See
         <a class="medical medical_review" href="/z/d/html/2939.html" rel="external">
          "Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis", section on 'Peripheral neurofibromas'
         </a>
         .)
        </p>
        <p>
         Most commonly, cutaneous neurofibroma occurs as a sporadic, solitary lesion in healthy adults. It typically presents as an asymptomatic, soft, skin-colored or hyperpigmented papule or nodule &lt;2 cm in diameter  (
         <a class="graphic graphic_picture graphicRef82612" href="/z/d/graphic/82612.html" rel="external">
          picture 2
         </a>
         ). Applying direct pressure to some neurofibromas may make them seem to retract into the skin, a finding that has been described as the "buttonhole" sign.
        </p>
        <p>
         The clinical differential diagnosis for neurofibromas often includes dermal melanocytic nevi  (
         <a class="graphic graphic_picture graphicRef76961" href="/z/d/graphic/76961.html" rel="external">
          picture 3
         </a>
         ) and acrochordon  (
         <a class="graphic graphic_picture graphicRef53025" href="/z/d/graphic/53025.html" rel="external">
          picture 1A
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/4846.html" rel="external">
          "Acquired melanocytic nevi (moles)"
         </a>
         and
         <a class="local">
          'Acrochordon (skin tag)'
         </a>
         above.)
        </p>
        <p>
         Treatment is not necessary for solitary cutaneous neurofibromas. Surgical excision can be used to remove lesions when the diagnosis is in question or when removal is desired due to discomfort or cosmetic concerns. Laser ablation, radiofrequency ablation, and electrodesiccation are additional options for patients with multiple tumors [
         <a href="#rid12">
          12
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/90123.html" rel="external">
          "Neurofibromatosis type 1 (NF1): Management and prognosis", section on 'Cutaneous and subcutaneous neurofibromas'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1101421982">
         <span class="h1">
          EPIDERMAL TUMORS
         </span>
        </p>
        <p class="headingAnchor" id="H1101421989">
         <span class="h2">
          Seborrheic keratosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Seborrheic keratosis is a common epidermal tumor consisting of a benign proliferation of immature keratinocytes [
         <a href="#rid13">
          13
         </a>
         ]. It is most commonly seen in middle-aged individuals, but it can also develop in young adults. There is a genetic predisposition to develop a high number of seborrheic keratoses, although the precise inheritance pattern is unknown. The pathogenesis is incompletely understood. Evidence for a role of cumulative ultraviolet (UV) radiation exposure or human papillomavirus (HPV) infection is inconsistent [
         <a href="#rid14">
          14
         </a>
         ]. Somatic activating mutations in the fibroblast growth factor receptor 3 (
         <em>
          FGFR3
         </em>
         ) and
         <em>
          PIK3CA
         </em>
         oncogenes have been found in seborrheic keratoses, but their pathogenetic role is uncertain [
         <a href="#rid15">
          15-18
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H69694337">
         <span class="h3">
          Clinical features
         </span>
         <span class="headingEndMark">
          —
         </span>
         Seborrheic keratosis presents as a well-demarcated, round or oval lesion with a dull, verrucous surface and a typical stuck-on appearance  (
         <a class="graphic graphic_picture graphicRef59020 graphicRef100059 graphicRef130299 graphicRef130300" href="/z/d/graphic/59020.html" rel="external">
          picture 4A-D
         </a>
         ). It is generally asymptomatic, but chronic irritation due to friction trauma may occasionally cause pruritus, pain, or bleeding. Seborrheic keratosis may vary in color, from skin colored to light brown, dark brown, or black.
        </p>
        <p>
         The number of seborrheic keratoses can vary from an isolated lesion to literally hundreds. A "Christmas tree" pattern may be seen on the back, due to lesion distribution along the Blaschko lines  (
         <a class="graphic graphic_picture graphicRef100065" href="/z/d/graphic/100065.html" rel="external">
          picture 5
         </a>
         ). The sign of Leser-Trélat, which refers to the sudden appearance of multiple seborrheic keratoses in association with skin tags and acanthosis nigricans, has been associated with a variety of malignancies, including gastrointestinal and lung cancers. Inflammation of preexisting seborrheic keratoses may occur during chemotherapy, in particular with
         <a class="drug drug_general" data-topicid="9314" href="/z/d/drug information/9314.html" rel="external">
          cytarabine
         </a>
         or
         <a class="drug drug_general" data-topicid="9381" href="/z/d/drug information/9381.html" rel="external">
          docetaxel
         </a>
         (pseudo-sign of Leser-Trélat) [
         <a href="#rid19">
          19,20
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7606.html" rel="external">
          "Cutaneous manifestations of internal malignancy", section on 'Sign of Leser-Trélat'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7606.html" rel="external">
          "Cutaneous manifestations of internal malignancy", section on 'Acanthosis nigricans'
         </a>
         .)
        </p>
        <p>
         Clinicopathologic variants of seborrheic keratosis include dermatosis papulosa nigra  (
         <a class="graphic graphic_picture graphicRef73398 graphicRef52430 graphicRef66252" href="/z/d/graphic/73398.html" rel="external">
          picture 6A-C
         </a>
         ), stucco keratosis  (
         <a class="graphic graphic_picture graphicRef100058" href="/z/d/graphic/100058.html" rel="external">
          picture 7
         </a>
         ), large cell acanthoma  (
         <a class="graphic graphic_picture graphicRef100061" href="/z/d/graphic/100061.html" rel="external">
          picture 8
         </a>
         ), clonal seborrheic keratosis, and irritated seborrheic keratosis. (See
         <a class="local">
          'Dermatosis papulosa nigra'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H69694376">
         <span class="h3">
          Diagnosis and differential diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of seborrheic keratosis is usually based on the clinical appearance of "stuck on," warty, well-circumscribed, often scaly hyperpigmented lesions located most commonly on the trunk, face, and upper extremities  (
         <a class="graphic graphic_picture graphicRef59020 graphicRef81260 graphicRef58923" href="/z/d/graphic/59020.html" rel="external">
          picture 4A, 4E-F
         </a>
         ). Close inspection with a hand lens often will demonstrate the presence of horn cysts or dark keratin plugs  (
         <a class="graphic graphic_picture graphicRef100062" href="/z/d/graphic/100062.html" rel="external">
          picture 9
         </a>
         ). Examination with a dermatoscope shows multiple milia cysts, comedo-like openings, and fissures and ridges forming a cerebriform pattern  (
         <a class="graphic graphic_picture graphicRef78870" href="/z/d/graphic/78870.html" rel="external">
          picture 10
         </a>
         ).
        </p>
        <p>
         Biopsy may be necessary if the diagnosis is uncertain or if there is concern for malignancy. Rare cases of seborrheic keratoses with associated basal cell carcinomas or melanomas (collision tumors) have been reported [
         <a href="#rid21">
          21-25
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5562.html" rel="external">
          "Office-based dermatologic diagnostic procedures"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5577.html" rel="external">
          "Skin biopsy techniques"
         </a>
         .)
        </p>
        <p>
         Histologically, seborrheic keratosis typically shows a well-demarcated proliferation of keratinocytes, with characteristic small keratin-filled cysts. A dermal lymphocytic infiltrate is often present in inflamed or irritated lesions.
        </p>
        <p>
         Seborrheic keratoses should be differentiated from other benign and malignant lesions, including:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acrochordon (see
         <a class="local">
          'Acrochordon (skin tag)'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Verruca vulgaris (see
         <a class="medical medical_review" href="/z/d/html/4029.html" rel="external">
          "Cutaneous warts (common, plantar, and flat warts)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Epidermal nevus (see
         <a class="medical medical_review" href="/z/d/html/13728.html" rel="external">
          "Epidermal nevus and epidermal nevus syndrome"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Melanocytic nevus (see
         <a class="medical medical_review" href="/z/d/html/4846.html" rel="external">
          "Acquired melanocytic nevi (moles)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basal cell carcinoma (see
         <a class="medical medical_review" href="/z/d/html/5335.html" rel="external">
          "Basal cell carcinoma: Epidemiology, pathogenesis, clinical features, and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Squamous cell carcinoma (see
         <a class="medical medical_review" href="/z/d/html/16225.html" rel="external">
          "Cutaneous squamous cell carcinoma (cSCC): Clinical features and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Melanoma (see
         <a class="medical medical_review" href="/z/d/html/15806.html" rel="external">
          "Melanoma: Clinical features and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         It is important that lesions with atypical clinical and dermoscopic features (eg, large lesions, history of rapid change or growth, ulcerated lesions) be biopsied for histopathologic examination [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H69694382">
         <span class="h3">
          Treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because seborrheic keratoses are benign and slow-growing lesions, treatment is generally not required. However, lesions that are symptomatic or that cause cosmetic concerns can be removed. Treatments commonly used in clinical practice include (see
         <a class="medical medical_review" href="/z/d/html/109151.html" rel="external">
          "Minor dermatologic procedures"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cryotherapy
         </strong>
         – Cryotherapy is the treatment most commonly used, particularly for flat or thin lesions. Cryotherapy should only be used if the clinical diagnosis is not in doubt. If a lesion returns after successful cryotherapy, it should be biopsied.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Curettage/shave excision
         </strong>
         – Curettage or shave excision, with submission of specimen for pathology, can be performed with a no. 15 scalpel blade after anesthesia with 1%
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Electrodesiccation
         </strong>
         – Electrodesiccation alone or followed by curettage usually requires anesthesia with 1%
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         .
        </p>
        <p>
        </p>
        <p>
         A variety of lasers, including pulsed carbon dioxide (CO
         <sub>
          2
         </sub>
         ) laser, erbium yttrium aluminium garnet (YAG) laser, 755 nm alexandrite laser, and 532 nm diode laser, have been also used for the treatment of seborrheic keratosis [
         <a href="#rid27">
          27-29
         </a>
         ]. However, none of the above treatments has been adequately evaluated in randomized trials. The choice of therapy is generally based upon the lesion size and thickness, patient's skin type, and clinical experience.
        </p>
        <p>
         In a small study of 25 patients, treatment of seborrheic keratoses with either cryotherapy or curettage with a no. 15 scalpel provided similar cosmetic improvement as rated by patients [
         <a href="#rid30">
          30
         </a>
         ]. However, most patients preferred cryotherapy over curettage due to the minimal postoperative wound care required with cryotherapy.
        </p>
        <p>
         Postinflammatory hypo- or hyperpigmentation and scarring may occur with healing. Postinflammatory hypopigmentation following cryotherapy is particularly frequent in individuals with darkly pigmented skin. (See
         <a class="medical medical_review" href="/z/d/html/95847.html" rel="external">
          "Postinflammatory hyperpigmentation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7279697">
         <span class="h2">
          Dermatosis papulosa nigra
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dermatosis papulosa nigra is characterized by the presence of multiple hyperpigmented papules measuring from 1 to 5 mm on the face and neck of individuals with darkly pigmented skin (Fitzpatrick skin types V and VI)  (
         <a class="graphic graphic_picture graphicRef73398 graphicRef100131" href="/z/d/graphic/73398.html" rel="external">
          picture 6A, 6D
         </a>
         ). There is a genetic predisposition to dermatosis papulosa nigra, with over 50 percent of patients reporting the condition in other family members [
         <a href="#rid31">
          31
         </a>
         ]. Typically, lesions are symmetrically distributed on the face; less frequently, they can occur on the neck and trunk.
        </p>
        <p>
         Histologically, dermatosis papulosa nigra lesions show acanthosis, papillomatosis, and hyperkeratosis and are considered a variant of seborrheic keratosis. However, in contrast with seborrheic keratosis, horn pseudocysts are usually absent.
        </p>
        <p>
         Some patients with multiple dermatosis papulosa nigra lesions may find them particularly cosmetically disturbing. The treatment of dermatosis papulosa nigra may also be challenging due to the high risk of post-treatment pigmentary alterations in patients with darkly pigmented skin.
        </p>
        <p>
         Treatment options include snip excision, curettage, electrodesiccation, and laser vaporization [
         <a href="#rid32">
          32,33
         </a>
         ]. Light electrodesiccation using low power settings is most commonly used. The application of a petrolatum-based ointment after the procedure may alleviate subjective symptoms of burning and pain and promote healing [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
         Cryotherapy should be avoided due to the high frequency of postinflammatory hypopigmentation in patients with darkly pigmented skin.
        </p>
        <p class="headingAnchor" id="H4115689115">
         <span class="h2">
          Clear cell acanthoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clear cell acanthoma (also called "Degos acanthoma") is a rare benign epidermal tumor of unknown etiology. It presents in older adults as a dome-shaped, erythematous papule or nodule a few millimeters to &gt;1 cm in size, often surrounded by a scaly collarette, most frequently located on the lower extremities  (
         <a class="graphic graphic_picture graphicRef142115 graphicRef142116" href="/z/d/graphic/142115.html" rel="external">
          picture 11A-B
         </a>
         ) [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
         Diagnosis is based on dermoscopic and histopathologic features. On dermoscopy, clear cell acanthoma shows pinpoint vessels arranged in a characteristic linear pattern resembling a "string of pearls"  (
         <a class="graphic graphic_picture graphicRef141522" href="/z/d/graphic/141522.html" rel="external">
          picture 12
         </a>
         ). Histopathology shows psoriasiform acanthosis and parakeratosis. The tumor cells are pale-staining keratinocytes replete with intracellular glycogen that stain positive with periodic acid-Schiff (PAS).
        </p>
        <p>
         Surgical excision is the preferred treatment.
        </p>
        <p class="headingAnchor" id="H1101420148">
         <span class="h1">
          APPENDAGEAL (ADNEXAL) TUMORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Benign appendageal tumors are relatively uncommon neoplasms that exhibit morphologic eccrine, apocrine, follicular, or sebaceous differentiation  (
         <a class="graphic graphic_table graphicRef98212" href="/z/d/graphic/98212.html" rel="external">
          table 1
         </a>
         ). They typically present as pink, skin-colored, or slightly bluish papules or nodules ranging in size from a few millimeters to several centimeters  (
         <a class="graphic graphic_picture graphicRef98463 graphicRef81221 graphicRef98399 graphicRef98389 graphicRef98390" href="/z/d/graphic/98463.html" rel="external">
          picture 13A-E
         </a>
         ).
        </p>
        <p>
         Benign and malignant cutaneous adnexal tumors are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/16910.html" rel="external">
          "Cutaneous adnexal tumors"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H59809494">
         <span class="h1">
          CYSTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         A cutaneous cyst is a sac-like lesion lined by an epithelium that presents as a dermal or subcutaneous papule or nodule. Several cyst subtypes can be distinguished based on the nature of the lining epithelium and cyst content. Common cutaneous cysts, including milia and epidermoid cysts, are lined by stratified squamous epithelium. Some cysts, including mucocele and digital myxoid cyst, are not lined by an epithelium.
        </p>
        <p class="headingAnchor" id="H2998132710">
         <span class="h2">
          Milium
         </span>
         <span class="headingEndMark">
          —
         </span>
         Milia are minute subepidermal keratin cysts that arise from the pilosebaceous units or eccrine sweat ducts. They present as firm, white papules, 1 to 2 mm in diameter, most frequently located on the face  (
         <a class="graphic graphic_picture graphicRef111106" href="/z/d/graphic/111106.html" rel="external">
          picture 14
         </a>
         ). Milia are common lesions; they occur at all ages and are a common finding in newborns. Histologically, milium consists of a wall of several layers of stratified squamous epithelium and a central keratinous material, similar to epidermoid cysts.
        </p>
        <p>
         In adults, when milia are small, they may at times be confused with other common lesions, such as flat warts or syringoma  (
         <a class="graphic graphic_picture graphicRef98458" href="/z/d/graphic/98458.html" rel="external">
          picture 15
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/16910.html" rel="external">
          "Cutaneous adnexal tumors", section on 'Syringoma'
         </a>
         ). Milia are reported to fluoresce bright yellow under Wood's lamp, and this may be used in cases of diagnostic uncertainty [
         <a href="#rid36">
          36
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/119230.html" rel="external">
          "Skin lesions in the newborn and infant"
         </a>
         .)
        </p>
        <p>
         Milia may develop spontaneously or as secondary lesions during the healing process of second-degree burns, blistering diseases (eg, epidermolysis bullosa, porphyria cutanea tarda), dermabrasion, and ablative laser resurfacing. They may also be an adverse effect of tyrosine kinase inhibitors [
         <a href="#rid37">
          37
         </a>
         ]. The so-called "milia en plaque" is an unusual lesion consisting of a cluster of milia occurring on an erythematous and edematous base, typically located in the retroauricular area and associated with autoimmune skin disorders.
        </p>
        <p>
         Milia are usually diagnosed based on clinical appearance.
        </p>
        <p>
         Milia can be treated for cosmetic reasons by incision of the overlying epidermis and expression of the content. Smaller lesions may respond to topical retinoids applied daily for several weeks. Recurrence is uncommon [
         <a href="#rid38">
          38,39
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1101420445">
         <span class="h2">
          Epidermoid cyst
         </span>
        </p>
        <p class="headingAnchor" id="H88286088">
         <span class="h3">
          Clinical features
         </span>
         <span class="headingEndMark">
          —
         </span>
         Epidermoid cyst, also called epidermal cyst, epidermal inclusion cyst, or, improperly, "sebaceous cyst," is the most common cutaneous cyst. It can occur anywhere on the body and typically presents as an asymptomatic, skin-colored dermal nodule  (
         <a class="graphic graphic_picture graphicRef100140" href="/z/d/graphic/100140.html" rel="external">
          picture 16C
         </a>
         ), often with a clinically visible central punctum  (
         <a class="graphic graphic_picture graphicRef130306 graphicRef100139" href="/z/d/graphic/130306.html" rel="external">
          picture 16A-B
         </a>
         ). The size ranges from a few millimeters to several centimeters in diameter. The cyst wall consists of normal stratified squamous epithelium derived from the follicular infundibulum.
        </p>
        <p>
         Epidermoid cysts unusual in number and location (extremities rather than the face, base of ears, and trunk) may be seen in the setting of Gardner syndrome, a rare, inherited condition characterized by familial adenomatous polyposis of the colon associated with several extracolonic abnormalities. (See
         <a class="medical medical_review" href="/z/d/html/2598.html" rel="external">
          "Gardner syndrome"
         </a>
         .)
        </p>
        <p>
         Epidermoid cysts may be primary or may arise from the implantation of the follicular epithelium in the dermis, as a result of trauma, or from a comedo. Lesions may remain stable or progressively enlarge. Spontaneous inflammation and rupture can occur, with significant involvement of surrounding tissue  (
         <a class="graphic graphic_picture graphicRef100141" href="/z/d/graphic/100141.html" rel="external">
          picture 17
         </a>
         ). There is no way to predict which lesions will remain quiescent and which will become larger or inflamed.
        </p>
        <p>
         Epidermoid cysts may become secondarily infected by the normal skin flora. Infected, fluctuant cysts tend to be larger, more erythematous, and more painful than sterile, inflamed cysts, although an intense, inflammatory response to cyst rupture may also occur in the absence of infection.
        </p>
        <p class="headingAnchor" id="H1787154894">
         <span class="h3">
          Diagnosis and differential diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of epidermoid cyst is usually clinical, based upon the clinical appearance of a discrete cyst or nodule, often with a central punctum, that is freely movable on palpation  (
         <a class="graphic graphic_picture graphicRef100139 graphicRef100140" href="/z/d/graphic/100139.html" rel="external">
          picture 16B-C
         </a>
         ). The diagnosis can be confirmed by histologic examination. The cyst wall consists of stratified squamous epithelium similar to skin surface or infundibulum of hair follicles. The cavity is filled with laminated layers of keratinous material. In ruptured cysts, a foreign-body inflammatory granulomatous reaction due to the release of the cyst content into the dermis may result in the formation of a keratin granuloma  (
         <a class="graphic graphic_picture graphicRef100143" href="/z/d/graphic/100143.html" rel="external">
          picture 18
         </a>
         ).
        </p>
        <p>
         The differential diagnosis of epidermoid cysts includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pilar cysts  (
         <a class="graphic graphic_picture graphicRef68396" href="/z/d/graphic/68396.html" rel="external">
          picture 23B
         </a>
         ) (see
         <a class="local">
          'Pilar (trichilemmal) cysts'
         </a>
         below).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lipoma  (
         <a class="graphic graphic_picture graphicRef71267 graphicRef100147" href="/z/d/graphic/71267.html" rel="external">
          picture 19A-B
         </a>
         ) (see
         <a class="local">
          'Lipoma'
         </a>
         below).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pilomatricoma  (
         <a class="graphic graphic_picture graphicRef81221 graphicRef98299" href="/z/d/graphic/81221.html" rel="external">
          picture 13B, 13F
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/16910.html" rel="external">
          "Cutaneous adnexal tumors", section on 'Pilomatricoma'
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abscess (see
         <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">
          "Acute cellulitis and erysipelas in adults: Treatment"
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ganglion cysts  (
         <a class="graphic graphic_picture graphicRef100145 graphicRef100146" href="/z/d/graphic/100145.html" rel="external">
          picture 20A-B
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/7761.html" rel="external">
          "Ganglion cysts of the wrist and hand", section on 'Definition'
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Steatocystoma multiplex (see
         <a class="local">
          'Steatocystoma multiplex'
         </a>
         below).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dermoid cyst – In infants and young children, a dermoid cyst is another possible confusing diagnosis. Dermoid cysts are congenital lesions that present as subcutaneous nodules seen along embryonic fusion lines on the face, scalp, and spine and contain epidermal and dermal tissues. The most common locations include the anterior fontanelle, the upper lateral region of the forehead near the eyebrow  (
         <a class="graphic graphic_picture graphicRef116052" href="/z/d/graphic/116052.html" rel="external">
          picture 21
         </a>
         ), and the submental region. Nasal dermoids, resulting from congenital fusion abnormalities at the nasal root, present as noncompressible masses over the nasal dorsum with an associated midline pit or punctum  (
         <a class="graphic graphic_picture graphicRef79363" href="/z/d/graphic/79363.html" rel="external">
          picture 22
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/120038.html" rel="external">
          "Cutaneous developmental anomalies in the newborn and infant"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6301.html" rel="external">
          "Congenital anomalies of the nose", section on 'Nasal dermoids'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H573782570">
         <span class="h3">
          Treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treatment of stable, uninfected epidermoid cysts is not necessary, unless desired by the patient. Inflamed, ruptured cysts that are not infected may resolve spontaneously without therapy, although they tend to recur. Injection of
         <a class="drug drug_general" data-topicid="10015" href="/z/d/drug information/10015.html" rel="external">
          triamcinolone
         </a>
         acetonide (3 mg/mL for the face and 10 mg/mL for the trunk) into the inflamed lesion can hasten the resolution of inflammation and may prevent infection and the need for incision and drainage. Only small amounts (enough to slightly distend the cyst) should be injected, since injection of larger amounts can result in rupture and scarring. If the lesion is fluctuant, incision and drainage is indicated rather than injection.
        </p>
        <p>
         Excision is best accomplished when the lesion is not inflamed; when the cyst is acutely inflamed the cyst wall is very friable, complete excision usually is not possible, and recurrence is likely. Thus, it is reasonable to wait until the inflammation has resolved before attempting excision. A description of cyst excision can be found separately. (See
         <a class="medical medical_review" href="/z/d/html/109151.html" rel="external">
          "Minor dermatologic procedures", section on 'Epidermoid cysts'
         </a>
         .)
        </p>
        <p>
         The punch incision technique and minimal incision technique are alternative methods to remove uncomplicated epidermoid cysts [
         <a href="#rid40">
          40-43
         </a>
         ]. A small incision is made on the cyst with a no. 11 surgical blade or 4 mm punch; the cyst content is then expressed by exerting a vigorous lateral pressure on the cyst  (
         <a class="graphic graphic_figure graphicRef100260" href="/z/d/graphic/100260.html" rel="external">
          figure 1
         </a>
         ). With this procedure, the cyst wall is usually released from the surrounding tissues and can be extracted through the small incision. The minimal incision technique provides better cosmetic results than the standard excision and is particularly useful for cysts in cosmetically sensitive areas. Recurrence rates of approximately &lt;1 to 8 percent have been reported with the minimal incision technique [
         <a href="#rid40">
          40,41,43
         </a>
         ].
        </p>
        <p>
         Fluctuant cysts require incision with a no. 11 blade and drainage of the purulent material after anesthesia with 1%
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         . Anesthesia should be injected around the lesion rather than into the lesion in order to avoid rupturing the cyst wall with the pressure of the anesthetic agent. (See
         <a class="medical medical_review" href="/z/d/html/6336.html" rel="external">
          "Techniques for skin abscess drainage"
         </a>
         .)
        </p>
        <p>
         The presence of significant surrounding cellulitis or cysts that have not responded to drainage may require oral antibiotic therapy, although in most cases the lesions are sterile. However, the drained contents should be sent for culture. Pending culture results, empiric antibiotic therapy can be started with agents active against methicillin-resistant
         <em>
          Staphylococcus aureus
         </em>
         (MRSA) in areas of high MRSA prevalence  (
         <a class="graphic graphic_table graphicRef64178" href="/z/d/graphic/64178.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">
          "Acute cellulitis and erysipelas in adults: Treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1101420695">
         <span class="h2">
          Pilar (trichilemmal) cysts
         </span>
         <span class="headingEndMark">
          —
         </span>
         A pilar cyst (trichilemmal cyst) resembles an epidermoid cyst, as it presents as a firm, slow-growing subcutaneous nodule. It is derived from the root sheath of the hair follicle and is most commonly located on the scalp  (
         <a class="graphic graphic_picture graphicRef65892 graphicRef68396" href="/z/d/graphic/65892.html" rel="external">
          picture 23A-B
         </a>
         ). Pilar cysts can occur sporadically or in the setting of a hereditary predisposition with autosomal dominant transmission [
         <a href="#rid44">
          44
         </a>
         ]. Patients with familial pilar cysts are often younger and often present with multiple lesions at the same time. Hereditary trichilemmal cysts appear to result from a two-hit mechanism involving germline and somatic variants of the phospholipase C Delta 1 gene (
         <em>
          PLCD1
         </em>
         ) [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
         Removal of pilar cysts is usually easier than removing epidermoid cysts, since the cyst wall is firm and tends not to rupture as easily. Enucleated cysts typically appear as firm, smooth, white nodules. Histologic examination of the removed lesion can confirm the diagnosis.
        </p>
        <p class="headingAnchor" id="H3238573620">
         <span class="h2">
          Vellus hair cyst
         </span>
         <span class="headingEndMark">
          —
         </span>
         Eruptive vellus hair cyst is a benign condition occurring in children and young adults characterized by a sudden appearance of small, follicular, dome-shaped papules, usually on the trunk  (
         <a class="graphic graphic_picture graphicRef100149" href="/z/d/graphic/100149.html" rel="external">
          picture 24
         </a>
         ) [
         <a href="#rid46">
          46
         </a>
         ]. The disorder is due to a developmental abnormality of the vellus hair follicle at the infundibular level and may be inherited in an autosomal dominant fashion. The diagnosis is based upon the histologic finding of a cystic structure located in the mid-dermis lined by squamous epithelium containing laminated keratinous material and numerous vellus hairs.
        </p>
        <p>
         Eruptive vellus hair cysts are usually asymptomatic and may slowly regress over several years. However, patients may require treatment for cosmetic reasons. Treatment modalities include incision and extraction, carbon dioxide (CO
         <sub>
          2
         </sub>
         ) laser or erbium-doped yttrium aluminium garnet (Er:YAG) laser vaporization, and topical retinoids [
         <a href="#rid47">
          47-49
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3846949402">
         <span class="h2">
          Steatocystoma multiplex
         </span>
         <span class="headingEndMark">
          —
         </span>
         Steatocystoma multiplex is an uncommon disorder characterized by multiple dermal, sebum-containing cysts measuring from less than 3 mm in diameter to 3 cm or more  (
         <a class="graphic graphic_picture graphicRef71097" href="/z/d/graphic/71097.html" rel="external">
          picture 25
         </a>
         ) [
         <a href="#rid50">
          50
         </a>
         ]. Lesions usually appear during adolescence or early adulthood and can occur anywhere on the body, including the scalp, intertriginous areas, and genitalia, but show a predilection for the chest.
        </p>
        <p>
         Steatocystoma multiplex is caused by mutations in the
         <em>
          KRT17
         </em>
         gene, which also cause a subtype of pachyonychia congenita [
         <a href="#rid51">
          51
         </a>
         ], and is a sporadic disorder in most cases, although it may be inherited as an autosomal dominant trait (see
         <a class="medical medical_review" href="/z/d/html/15504.html" rel="external">
          "Pachyonychia congenita"
         </a>
         ). Histopathologically, lesions consist of dermal cyst lined by a thin wall of stratified squamous epithelium containing small sebaceous gland lobules and sebum.
        </p>
        <p>
         Treatment is difficult, due to the high number of lesions. Options include surgical excision, incision and expression of the cyst content followed by extraction of the cyst wall, and carbon dioxide laser therapy [
         <a href="#rid52">
          52-54
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3062277978">
         <span class="h2">
          Mucocele
         </span>
         <span class="headingEndMark">
          —
         </span>
         A mucocele is a common, benign, cystic lesion most frequently found in the lower lip mucosa  (
         <a class="graphic graphic_picture graphicRef70332" href="/z/d/graphic/70332.html" rel="external">
          picture 26
         </a>
         ). It results from mucin leakage from a disrupted salivary duct, in most cases as a consequence of an intraoral trauma (eg, repetitive lip biting). (See
         <a class="medical medical_review" href="/z/d/html/5572.html" rel="external">
          "Oral lesions", section on 'Mucoceles'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H58683733">
         <span class="h2">
          Digital myxoid cyst
         </span>
         <span class="headingEndMark">
          —
         </span>
         A digital myxoid cyst or myxoid pseudocyst (also called mucous or mucoid cyst) typically presents as a translucent nodule on the dorsum of the digit between the distal interphalangeal joint and the proximal nail fold  (
         <a class="graphic graphic_picture graphicRef85602" href="/z/d/graphic/85602.html" rel="external">
          picture 27
         </a>
         ). It results from mucoid degeneration of the connective tissue and/or joint fluid leaking from an osteoarthritic distal interphalangeal joint by way of a communicating canal. The diagnosis and treatment of digital myxoid cysts are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/16202.html" rel="external">
          "Principles and overview of nail surgery", section on 'Digital myxoid cyst'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13682.html" rel="external">
          "Overview of nail disorders", section on 'Digital myxoid cyst or myxoid pseudocyst'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1101420658">
         <span class="h1">
          VASCULAR TUMORS
         </span>
        </p>
        <p class="headingAnchor" id="H105711467">
         <span class="h2">
          Infantile hemangioma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infantile hemangiomas are benign tumors of vascular endothelium and the most common tumors of childhood  (
         <a class="graphic graphic_picture graphicRef126983" href="/z/d/graphic/126983.html" rel="external">
          picture 28
         </a>
         ). The clinical presentation, diagnosis, and management of infantile hemangiomas are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5794.html" rel="external">
          "Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5793.html" rel="external">
          "Infantile hemangiomas: Evaluation and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5792.html" rel="external">
          "Infantile hemangiomas: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Cherry angioma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cherry angiomas, also known as Campbell de Morgan spots, are mature capillary proliferations that are common in middle-aged and older adult patients. They tend to be less conspicuous in individuals with darkly pigmented skin. They usually occur as multiple lesions, most commonly on the trunk, and bleed profusely with any traumatic rupture. The pathogenesis is incompletely understood. Oncogenic mutations in
         <em>
          GNAQ
         </em>
         and
         <em>
          GNA11
         </em>
         , similar to those found in port wine birthmarks and Sturge-Weber syndrome, have been found in 50 percent of tissue samples [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
         Cherry angiomas are most often dome shaped and red to dark red, typically 0.1 to 0.4 cm in diameter, and do not usually blanch with pressure  (
         <a class="graphic graphic_picture graphicRef54605 graphicRef63468" href="/z/d/graphic/54605.html" rel="external">
          picture 29A-B
         </a>
         ).
        </p>
        <p>
         The diagnosis is based on the clinical appearance of the lesions. Examination with a dermatoscope shows characteristic red, purple, or blue-black lagoons  (
         <a class="graphic graphic_picture graphicRef66439" href="/z/d/graphic/66439.html" rel="external">
          picture 30
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/13522.html" rel="external">
          "Dermoscopic evaluation of skin lesions"
         </a>
         .)
        </p>
        <p>
         Cherry angiomas may be confused with amelanotic melanomas, which are usually friable lesions that may have recently changed in size or configuration  (
         <a class="graphic graphic_picture graphicRef127583" href="/z/d/graphic/127583.html" rel="external">
          picture 31
         </a>
         ). If there is any concern for malignancy, the lesion should be excised and sent for histopathologic examination.
        </p>
        <p>
         Treatment of cherry angiomas is only necessary for patients who are bothered by the lesions. Patients should be advised, however, that new lesions are likely to develop and there is no known way to prevent them.
        </p>
        <p>
         The following modes of treatment may be used [
         <a href="#rid56">
          56
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Small lesions can be electrocauterized after local anesthesia with 1%
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Shave excision and electrocauterization of the base is useful for larger lesions.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Laser therapy can also be used to remove superficial lesions. (See
         <a class="medical medical_review" href="/z/d/html/13638.html" rel="external">
          "Laser and light therapy for cutaneous vascular lesions"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cryotherapy.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H14616733">
         <span class="h2">
          Pyogenic granuloma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pyogenic granuloma or lobular capillary hemangioma is a benign vascular tumor of the skin  (
         <a class="graphic graphic_picture graphicRef52128 graphicRef52429 graphicRef60189 graphicRef67395" href="/z/d/graphic/52128.html" rel="external">
          picture 32A-D
         </a>
         ) or mucous membranes  (
         <a class="graphic graphic_picture graphicRef66965" href="/z/d/graphic/66965.html" rel="external">
          picture 33
         </a>
         ) characterized by rapid growth and friable surface that bleeds profusely after minor trauma. Pyogenic granuloma occurs in patients of all ages, with a peak incidence in the second and third decade of life and during pregnancy. The cause of this is unknown. Reported trigger factors include trauma and medications.
        </p>
        <p>
         Pyogenic granuloma is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/13736.html" rel="external">
          "Pyogenic granuloma (lobular capillary hemangioma)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1101420944">
         <span class="h1">
          TUMORS OF SUBCUTANEOUS FAT
         </span>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Lipoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Superficial subcutaneous lipomas are the most common benign soft-tissue neoplasms. They consist of mature fat cells enclosed by thin fibrous capsules. Lipomas can occur on any part of the body and usually develop superficially in the subcutaneous tissue. Rarely, they may involve fascia or deeper muscular planes.
        </p>
        <p>
         Lipomas present as soft, painless subcutaneous nodules ranging in size from 1 to &gt;10 cm. They occur most frequently on the trunk and upper extremities and can be round, oval, or multilobulated  (
         <a class="graphic graphic_picture graphicRef100147 graphicRef71267" href="/z/d/graphic/100147.html" rel="external">
          picture 19A-B
         </a>
         ). Frequently, patients may have more than one lipoma. Malignant transformation of a lipoma into a liposarcoma is rare.
        </p>
        <p>
         The diagnosis of lipoma is usually made clinically. Ultrasound examination can be helpful to distinguish a lipoma from an epidermoid cyst or a ganglion cyst [
         <a href="#rid57">
          57
         </a>
         ]. If a suspected lipoma causes symptoms (pain or restriction of movement), is rapidly enlarging, or is firm rather than soft, a biopsy is indicated to confirm the diagnosis and exclude malignancy (eg, liposarcoma).
        </p>
        <p>
         The treatment of lipomas, if needed because of pain, cosmesis, or concerns over diagnosis, is surgical removal of the fat cells and fibrous capsule. Recurrence of an excised lipoma is not common.
        </p>
        <p>
         Side effects of surgery include scarring, seroma, and hematoma formation. In areas that are cosmetically sensitive, a surgical technique with segmental extraction and minimal surface incision may limit the scar size [
         <a href="#rid58">
          58
         </a>
         ]. Alternative treatment modalities include liposuction and injection with low concentrations of deoxycholate [
         <a href="#rid59">
          59,60
         </a>
         ]. Deoxycholate injections led to improvement in a small study of six patients [
         <a href="#rid60">
          60,61
         </a>
         ]. However, further studies are necessary before this agent can be routinely recommended.
        </p>
        <p class="headingAnchor" id="H2977636186">
         <span class="h2">
          Lipomatoses
         </span>
        </p>
        <p class="headingAnchor" id="H1150868706">
         <span class="h3">
          Multiple symmetric lipomatosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple symmetric lipomatosis (also called benign symmetric lipomatosis, Madelung disease, or Launois-Bensaude disease) is a rare disorder of unknown etiology characterized by multiple symmetric, unencapsulated fat deposits involving multiple areas of the body [
         <a href="#rid62">
          62
         </a>
         ]. Excessive alcohol consumption and mitochondrial dysfunction have been implicated in the pathogenesis of multiple symmetric lipomatosis, although the exact mechanisms remain unknown. Autosomal recessive forms (MIM #151800) associated with variants in the
         <em>
          MNF2
         </em>
         gene, encoding mitofusin 2, have been reported [
         <a href="#rid63">
          63,64
         </a>
         ].
        </p>
        <p>
         Multiple symmetric lipomatosis presents in adults 30 to 60 years of age, predominantly in males [
         <a href="#rid65">
          65
         </a>
         ]. The areas most commonly involved are the neck, shoulders, and proximal upper limbs. Less frequently, fat deposits are located on the abdomen and upper thighs.
        </p>
        <p>
         The clinical course is slowly progressive. Associated disorders include (among others) chronic liver disease, metabolic syndrome, dyslipidemia, hypertension, peripheral neuropathy, and diabetes [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
         The diagnosis of multiple symmetric lipomatosis is usually clinical. The differential diagnosis includes obesity, Dercum disease, and familial multiple lipomatosis.
        </p>
        <p>
         Treatment includes surgical excision (lipectomy), liposuction, or a combination of the two. In a series of 59 surgical cases, recurrence at the site of surgery occurred in 39 percent of patients in a mean time of 3.8 years [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3583783062">
         <span class="h3">
          Familial multiple lipomatosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Familial multiple lipomatosis is a rare autosomal dominant disorder characterized by the development of multiple lipomas mainly located on the arms, trunk, and legs  (
         <a class="graphic graphic_picture graphicRef61498" href="/z/d/graphic/61498.html" rel="external">
          picture 34
         </a>
         ) [
         <a href="#rid67">
          67
         </a>
         ]. Familial multiple lipomatosis becomes apparent during adolescence or early adulthood. The genetic alteration underlying familial multiple lipomatosis has not been identified.
        </p>
        <p class="headingAnchor" id="H467320757">
         <span class="h3">
          Dercum disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dercum disease (also called adiposis dolorosa, lipomatosis dolorosa, and adipose tissue rheumatism) is a rare disorder of unknown etiology characterized by multiple painful, subcutaneous lipomas or angiolipomas in individuals (predominantly females) who are obese [
         <a href="#rid68">
          68
         </a>
         ]. Lipomatous nodules are most frequently located on the proximal extremities, trunk, pelvic area, and buttocks. Associated conditions include mood disorders, chronic fatigue syndrome, chronic pain, and fibromyalgia [
         <a href="#rid69">
          69
         </a>
         ]. Liposuction has been reported as beneficial in small case series [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6276055">
         <span class="h2">
          Angiolipoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Angiolipoma is a benign tumor of adipocytes typically occurring in adolescents and young adults. Angiolipoma presents as a soft subcutaneous nodule of 0.5 to 2 cm in diameter, usually located on the forearm and chest wall  (
         <a class="graphic graphic_picture graphicRef67098" href="/z/d/graphic/67098.html" rel="external">
          picture 35
         </a>
         ). Lesions are frequently multiple. Angiolipomas have been reported in individuals infected with human immunodeficiency virus (HIV) after starting antiretroviral therapy [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
         Clinically, angiolipomas closely resemble lipomas, although angiolipomas are usually painful and tender. Histopathologic examination is necessary for diagnosis. Macroscopically, angiolipoma appears as a small, well-circumscribed, subcutaneous tumor  (
         <a class="graphic graphic_picture graphicRef100268" href="/z/d/graphic/100268.html" rel="external">
          picture 36
         </a>
         ); histology reveals a circumscribed, encapsulated tumor composed of an admixture of mature adipose cells and capillary vessels. Fibrin thrombi are typically seen. Occasionally, a predominance of blood vessels can be seen (cellular angiolipomas). The vascular proliferation component is not seen in lipomas.
        </p>
        <p>
         Single, painful lesions can be excised. The treatment of multiple lesions is difficult. Liposuction has been used in a few cases [
         <a href="#rid72">
          72,73
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14616899">
         <span class="h1">
          GLOMUS TUMOR
         </span>
         <span class="headingEndMark">
          —
         </span>
         Glomus tumor is a rare, benign neoplasm composed of cells resembling the modified smooth muscle cells of the normal glomus body [
         <a href="#rid74">
          74
         </a>
         ]. It is usually located in areas of the skin that are rich in glomus bodies (eg, the subungual regions of digits or the deep dermis of the palm, wrist, forearm, and foot). Glomus tumors of the fingers and toes occur in approximately 5 percent of patients with neurofibromatosis type 1 (NF1) and are considered NF1-associated neoplasms [
         <a href="#rid75">
          75-77
         </a>
         ].
        </p>
        <p>
         Glomus tumor presents as a pink or purple vascular papule or nodule associated with paroxysmal pain, cold sensitivity, and tenderness. Subungual glomus tumors are particularly painful. Nail dystrophy and/or a bluish-red flush are typically seen  (
         <a class="graphic graphic_picture graphicRef51899 graphicRef61115 graphicRef72924" href="/z/d/graphic/51899.html" rel="external">
          picture 37A-C
         </a>
         ).
        </p>
        <p>
         The diagnosis is suspected on the basis of the clinical appearance and history of paroxysmal pain and cold sensitivity. Histopathologic examination of the excised tumor is necessary to confirm the diagnosis.
        </p>
        <p>
         Histologically, glomus tumor is a well-circumscribed dermal nodule composed of glomus cells, vasculature, and smooth muscle cells  (
         <a class="graphic graphic_picture graphicRef100269" href="/z/d/graphic/100269.html" rel="external">
          picture 38
         </a>
         ). Solid glomus tumor, with scarce vasculature and scant muscle component, is the most common variant [
         <a href="#rid74">
          74
         </a>
         ]. Less common variants include glomangioma, with prominent vascular component, and glomangiomyoma, with prominent vascular and smooth muscle components.
        </p>
        <p>
         Treatment is surgical excision. For subungual tumors, preoperative imaging studies with color Doppler ultrasonography and magnetic resonance may provide information on tumor size, shape, and precise anatomic location [
         <a href="#rid78">
          78
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16202.html" rel="external">
          "Principles and overview of nail surgery", section on 'Glomus tumors'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1101421337">
         <span class="h1">
          PIGMENTED LESIONS
         </span>
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h2">
          Melanocytic nevus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Melanocytic nevi (moles) are common neoplasms that result from the proliferation of cutaneous melanocytes. Nevi frequently present as pigmented macules, papules, or plaques but may also be skin colored or pink. (See
         <a class="medical medical_review" href="/z/d/html/4846.html" rel="external">
          "Acquired melanocytic nevi (moles)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4847.html" rel="external">
          "Congenital melanocytic nevi"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1101421390">
         <span class="h2">
          Solar lentigo
         </span>
         <span class="headingEndMark">
          —
         </span>
         Solar lentigo, most commonly known as liver spots, "old age spots," or "sunspots," is a proliferation of normal melanocytes secondary to chronic solar damage. These lesions occur most commonly in individuals with lightly pigmented skin who have a history of chronic sun exposure. Hyperpigmentation may vary from light to dark brown but is uniform within an individual lesion. (See
         <a class="medical medical_review" href="/z/d/html/5560.html" rel="external">
          "Benign pigmented skin lesions other than melanocytic nevi (moles)", section on 'Solar lentigo'
         </a>
         .)
        </p>
        <p>
         Diagnosis is based on the clinical appearance of flat, oval, evenly pigmented macules in areas of chronic sun exposure, particularly the face, dorsa of the hands, shoulders, and back  (
         <a class="graphic graphic_picture graphicRef86484 graphicRef61452" href="/z/d/graphic/86484.html" rel="external">
          picture 39A-B
         </a>
         ). However, lesions that are reported to have changed color, variability in color, irregular margins, or developed a papular or nodular component should be biopsied to exclude malignancy.
        </p>
        <p>
         The differential diagnosis of solar lentigines includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Seborrheic keratosis
         </strong>
         – Early, macular seborrheic keratoses may be difficult to differentiate from solar lentigines. Scale and palpable components are features of seborrheic keratoses. (See
         <a class="local">
          'Seborrheic keratosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lentigo maligna
         </strong>
         – Lesions have variable pigmentation, irregular borders, and a history of gradual enlargement  (
         <a class="graphic graphic_picture graphicRef59591 graphicRef68787 graphicRef77206" href="/z/d/graphic/59591.html" rel="external">
          picture 40A-C
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/13520.html" rel="external">
          "Lentigo maligna: Clinical manifestations, diagnosis, and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lentigo maligna melanoma
         </strong>
         – Lentigo maligna melanoma has an irregular border, variable pigmentation, and may have a raised papule or nodule within the plaque  (
         <a class="graphic graphic_picture graphicRef74664 graphicRef57765" href="/z/d/graphic/74664.html" rel="external">
          picture 41A-B
         </a>
         ). The history is of gradual change, usually over years. (See
         <a class="medical medical_review" href="/z/d/html/13520.html" rel="external">
          "Lentigo maligna: Clinical manifestations, diagnosis, and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         No treatment is needed unless the patient desires removal for cosmetic reasons. Liquid nitrogen applied for 5 seconds or less can be used if treatment is desired. Lesions may heal with hypopigmentation.
        </p>
        <p>
         Patients should be educated on the use of sunscreens and sun protection. Regular use of sunscreens prevents the development of solar lentigines, although it does not lead to regression of current lesions [
         <a href="#rid79">
          79
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8539" href="/z/d/drug information/8539.html" rel="external">
          Hydroquinone
         </a>
         cream 4% or triple combination cream with
         <a class="drug drug_general" data-topicid="8458" href="/z/d/drug information/8458.html" rel="external">
          fluocinolone
         </a>
         acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% plus sun protection can lighten existing lesions and reduce postinflammatory hyperpigmentation after cryotherapy [
         <a href="#rid80">
          80
         </a>
         ]. Thin seborrheic keratoses, which are sometimes mistaken for lentigines, will not respond to topical hydroquinone.
        </p>
        <p class="headingAnchor" id="H578798509">
         <span class="h2">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other benign pigmented lesions, including café-au-lait spots, Becker nevus, and dermal melanocytosis, are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5560.html" rel="external">
          "Benign pigmented skin lesions other than melanocytic nevi (moles)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1518657374">
         <span class="h1">
          OTHER BENIGN SKIN LESIONS
         </span>
        </p>
        <p class="headingAnchor" id="H44818748">
         <span class="h2">
          Chondrodermatitis nodularis helicis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chondrodermatitis nodularis helicis is a solitary, firm, painful nodule &lt;10 mm in size, located on the helix or, less frequently, on the antihelix of the ear [
         <a href="#rid81">
          81
         </a>
         ]. It is thought to result from cartilage inflammation that in extreme cases may cause cartilage necrosis and transepithelial elimination of degenerated collagen. Etiologic factors include chronic trauma, chronic sun exposure, low temperature, and prolonged or excessive pressure with compromise of local blood supply. An association with systemic diseases, including connective tissue and cardiovascular disease, also has been suggested [
         <a href="#rid82">
          82
         </a>
         ].
        </p>
        <p>
         Chondrodermatitis nodularis helicis most often occurs in middle-aged or older males, but it can occur in females or younger patients. It is usually unilateral and typically develops on the same side the patient lies on in bed  (
         <a class="graphic graphic_picture graphicRef89905" href="/z/d/graphic/89905.html" rel="external">
          picture 42
         </a>
         ) [
         <a href="#rid81">
          81
         </a>
         ]. The nodule enlarges rapidly over a few months and then remains stable. The surface is frequently covered with a scale or crust that conceals a small ulcer. Pain is initiated by pressure or by changes in the ambient temperature and lasts from a few minutes to a few hours.
        </p>
        <p>
         Diagnosis is based upon the clinical appearance and history of rapid development of a nodular lesion with associated pain and tenderness. If the diagnosis is in doubt, the lesion should be excised and sent for histopathologic examination. Histology shows a nodule of degenerated collagen surrounded by a lymphohistiocytic infiltrate; a central ulceration through which the degenerated collagen is extruded is often present. The differential diagnosis includes hypertrophic actinic keratosis, basal cell carcinoma  (
         <a class="graphic graphic_picture graphicRef89919" href="/z/d/graphic/89919.html" rel="external">
          picture 43
         </a>
         ), keratoacanthoma  (
         <a class="graphic graphic_picture graphicRef81629" href="/z/d/graphic/81629.html" rel="external">
          picture 44
         </a>
         ), squamous cell carcinoma  (
         <a class="graphic graphic_picture graphicRef89920" href="/z/d/graphic/89920.html" rel="external">
          picture 45
         </a>
         ), and tophus  (
         <a class="graphic graphic_picture graphicRef89918" href="/z/d/graphic/89918.html" rel="external">
          picture 46
         </a>
         ).
        </p>
        <p>
         Conservative treatment includes strategies to relieve pressure and intralesional corticosteroids. Relieving pressure is the most important aspect of managing these lesions. The use of a donut-shaped pillow or foam padding for several weeks may provide resolution of symptoms [
         <a href="#rid83">
          83-86
         </a>
         ]. Intralesional injection of
         <a class="drug drug_general" data-topicid="10015" href="/z/d/drug information/10015.html" rel="external">
          triamcinolone
         </a>
         acetonide 10 mg/mL may provide rapid pain relief in most patients and long-term resolution of chondrodermatitis nodularis helicis in some [
         <a href="#rid87">
          87
         </a>
         ]. Monthly treatments may be necessary up to three to four treatments. Other treatments that have been evaluated in small numbers of patients include 2% topical
         <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">
          nitroglycerin
         </a>
         and photodynamic therapy [
         <a href="#rid88">
          88-92
         </a>
         ].
        </p>
        <p>
         Surgical approaches include cryotherapy, curettage, carbon dioxide laser ablation, wedge excision, and cartilage removal alone [
         <a href="#rid93">
          93-98
         </a>
         ]. Recurrence after surgical excision has been reported in 10 to 30 percent of patients [
         <a href="#rid85">
          85,99
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H36">
         <span class="h2">
          Venous lake
         </span>
         <span class="headingEndMark">
          —
         </span>
         Venous lakes are lesions of dilated venous capillaries on the face, lips, and ears of older adult patients. The lesions bleed easily following minor trauma.
        </p>
        <p>
         Diagnosis is based upon the appearance of the blue lesion in characteristic locations that disappear when compressed with a glass slide  (
         <a class="graphic graphic_picture graphicRef82615" href="/z/d/graphic/82615.html" rel="external">
          picture 47
         </a>
         ). Venous lakes should be differentiated from blue nevi, which do not disappear with compression and do not usually appear on the face, ears, or lips. Nodular melanomas also can be confused with venous lakes, but do not disappear with compression, remaining a firm nodule.
        </p>
        <p>
         Electrosurgery after anesthesia with 1%
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         can be used if the lesion causes a bleeding problem or is cosmetically unacceptable. Pulsed dye vascular laser may remove lesions without causing a scar [
         <a href="#rid100">
          100
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1101420580">
         <span class="h2">
          Calluses and corns
         </span>
         <span class="headingEndMark">
          —
         </span>
         Calluses and corns (clavi) are among the most frequent skin conditions and, by virtue of their location on the feet, may be the source of considerable disability, discomfort, and pain [
         <a href="#rid101">
          101
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Calluses are a diffuse thickening of the outermost layer of the skin, the stratum corneum, in response to repeated friction or pressure  (
         <a class="graphic graphic_picture graphicRef86486" href="/z/d/graphic/86486.html" rel="external">
          picture 48
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Corns develop similarly, but differ by having a central "core" that is hyperkeratotic and often painful  (
         <a class="graphic graphic_picture graphicRef76048 graphicRef56092" href="/z/d/graphic/76048.html" rel="external">
          picture 49A-B
         </a>
         ). Corns typically occur at pressure points secondary to ill-fitting shoes, an underlying bony spur, or an abnormal gait.
        </p>
        <p>
        </p>
        <p>
         These lesions are typically located on the plantar aspect of prominent metatarsals, between toe clefts, or on the dorsal aspect of toe joints.
        </p>
        <p>
         The diagnosis of calluses and corns is based upon their clinical appearance. They must be differentiated from plantar warts. After paring down, warts will have several dark specks that represent punctate capillary thromboses. Warts also disrupt normal skin markings so that the skin lines are no longer evident. Skin lines are more prominent in callosities.
        </p>
        <p>
         Treatment of calluses and corns begins with prevention. Patients should be advised to avoid ill-fitting shoes. Consider referring patients with severe, recurrent problems for orthotic consultation to fit inner soles or metatarsal bars, particularly if patients have diabetes and neuropathic and vascular involvement of the lower extremities. (See
         <a class="medical medical_review" href="/z/d/html/1749.html" rel="external">
          "Evaluation of the diabetic foot"
         </a>
         .)
        </p>
        <p>
         In most cases, calluses or corns can be treated conservatively with the application of keratolytics, such as salicylic acid (plasters or ointment) or urea-based creams. Scalpel debridement may be an alternative treatment to achieve a more rapid decrease of pain and improvement in function [
         <a href="#rid102">
          102
         </a>
         ]. However, the long-term resolution of callus appears to be similar with both approaches [
         <a href="#rid103">
          103
         </a>
         ]. Referral to podiatry to evaluate for an underlying bony abnormality should be considered for patients with lesions that are recalcitrant or recurrent:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Salicylic acid plaster
         </strong>
         – Salicylic acid plaster 40% is available without a prescription and is used as follows:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Debulk the callus or corn by paring skin with a no. 15 scalpel blade.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cut the plaster to the size of the lesion and apply. Tape can be used to keep the patch in place and avoid it slipping onto unaffected areas.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Leave in place for 48 hours.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pare down the remaining skin; replace the plaster patch and let the patient resume proper foot care and continue applying the patch at home.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patients should be advised to remove the white, "dead" skin with a metal nail file or pumice stone each night before replacing the patch. Soaking the skin in warm water for five minutes before using a nail file or pumice stone can help in removing the "dead" skin.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Use of the patch should stop once the lesion has resolved.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Follow-up if lesions do not resolve within one to two weeks.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Do
         <strong>
          not
         </strong>
         use plaster in patients with peripheral neuropathies. These patients may not notice pain with improper patch placement and can develop damage to normal skin.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Salicylic acid ointment
         </strong>
         – Salicylic acid 10 to 20% in petrolatum (available in 30 to 45 g tubes) is available by prescription and compounded by a pharmacist. The ointment is applied in a small amount on the callus under occlusion nightly. Patients with peripheral neuropathies should
         <strong>
          not
         </strong>
         use salicylic acid ointments.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Urea
         </strong>
         <strong>
          -based creams
         </strong>
         – Creams containing 40% urea, especially under occlusion overnight, can assist with callus removal similarly to salicylic acid. High-concentration urea creams should be used under medical supervision in patients with peripheral neuropathies and diminished sensation in the feet.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7769090">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/83336.html" rel="external">
          "Patient education: Skin tags (acrochordon) (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/83445.html" rel="external">
          "Patient education: Seborrheic keratosis (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/83620.html" rel="external">
          "Patient education: Corns and calluses (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H39">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnostic approach
         </strong>
         – Most benign skin lesions are diagnosed on the basis of clinical appearance (morphology, distribution) and history (see
         <a class="medical medical_review" href="/z/d/html/6838.html" rel="external">
          "Approach to the clinical dermatologic diagnosis"
         </a>
         ). Dermoscopy, a skin examination technique performed with a handheld instrument called a dermatoscope, is a helpful adjunct to the clinical examination of a variety of pigmented and nonpigmented lesions (see
         <a class="medical medical_review" href="/z/d/html/13522.html" rel="external">
          "Dermoscopic evaluation of skin lesions"
         </a>
         ). If the diagnosis of a lesion is uncertain or if a lesion has exhibited unexpected changes in appearance or symptoms, a diagnostic procedure (eg, biopsy, excision) is indicated to confirm the diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/5577.html" rel="external">
          "Skin biopsy techniques"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dermal tumors
         </strong>
         – Common dermal tumors include acrochordon (skin tag  (
         <a class="graphic graphic_picture graphicRef70871 graphicRef78524 graphicRef78625 graphicRef58450 graphicRef65856 graphicRef53025" href="/z/d/graphic/70871.html" rel="external">
          picture 1A-F
         </a>
         )), dermatofibroma  (
         <a class="graphic graphic_picture graphicRef80587 graphicRef68729 graphicRef80575" href="/z/d/graphic/80587.html" rel="external">
          picture 50A-C
         </a>
         ), and cutaneous neurofibroma  (
         <a class="graphic graphic_picture graphicRef82612" href="/z/d/graphic/82612.html" rel="external">
          picture 2
         </a>
         ). (See
         <a class="local">
          'Dermal tumors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidermal tumors
         </strong>
         – Common benign epidermal (keratinocyte) tumors include seborrheic keratosis  (
         <a class="graphic graphic_picture graphicRef59020 graphicRef100126 graphicRef100059" href="/z/d/graphic/59020.html" rel="external">
          picture 4A-B, 4G
         </a>
         ) and dermatosis papulosa nigra. (See
         <a class="local">
          'Seborrheic keratosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adnexal tumors
         </strong>
         – Benign adnexal (appendageal) tumors, including sebaceous hyperplasia  (
         <a class="graphic graphic_picture graphicRef98390" href="/z/d/graphic/98390.html" rel="external">
          picture 13E
         </a>
         ), poroma  (
         <a class="graphic graphic_picture graphicRef98463" href="/z/d/graphic/98463.html" rel="external">
          picture 13A
         </a>
         ), and pilomatricoma  (
         <a class="graphic graphic_picture graphicRef81221" href="/z/d/graphic/81221.html" rel="external">
          picture 13B
         </a>
         ), are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/16910.html" rel="external">
          "Cutaneous adnexal tumors"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cysts
         </strong>
         – Cutaneous cysts include milium, epidermoid cyst  (
         <a class="graphic graphic_picture graphicRef55769 graphicRef50581" href="/z/d/graphic/55769.html" rel="external">
          picture 51A-B
         </a>
         ), pilar cyst  (
         <a class="graphic graphic_picture graphicRef66512 graphicRef65892" href="/z/d/graphic/66512.html" rel="external">
          picture 23A, 23C
         </a>
         ), vellus hair cyst  (
         <a class="graphic graphic_picture graphicRef100149" href="/z/d/graphic/100149.html" rel="external">
          picture 24
         </a>
         ), and digital myxoid cyst  (
         <a class="graphic graphic_picture graphicRef85602" href="/z/d/graphic/85602.html" rel="external">
          picture 27
         </a>
         ). Mucocele is a common cystic lesion most frequently found in the lower lip mucosa  (
         <a class="graphic graphic_picture graphicRef70332" href="/z/d/graphic/70332.html" rel="external">
          picture 26
         </a>
         ). (See
         <a class="local">
          'Cysts'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vascular tumors
         </strong>
         – Benign vascular tumors include infantile hemangioma  (
         <a class="graphic graphic_picture graphicRef126983" href="/z/d/graphic/126983.html" rel="external">
          picture 28
         </a>
         ), pyogenic granuloma  (
         <a class="graphic graphic_picture graphicRef52128 graphicRef52429 graphicRef60189 graphicRef67395" href="/z/d/graphic/52128.html" rel="external">
          picture 32A-D
         </a>
         ), and cherry hemangioma  (
         <a class="graphic graphic_picture graphicRef54605 graphicRef63468" href="/z/d/graphic/54605.html" rel="external">
          picture 29A-B
         </a>
         ) (see
         <a class="local">
          'Vascular tumors'
         </a>
         above). Infantile hemangioma and pyogenic granuloma are discussed in separate topic reviews. (See
         <a class="medical medical_review" href="/z/d/html/5794.html" rel="external">
          "Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13736.html" rel="external">
          "Pyogenic granuloma (lobular capillary hemangioma)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tumors of subcutaneous fat
         </strong>
         – Common tumors of subcutaneous fat include lipoma  (
         <a class="graphic graphic_picture graphicRef71267" href="/z/d/graphic/71267.html" rel="external">
          picture 19A
         </a>
         ) and angiolipoma  (
         <a class="graphic graphic_picture graphicRef67098" href="/z/d/graphic/67098.html" rel="external">
          picture 35
         </a>
         ). (See
         <a class="local">
          'Tumors of subcutaneous fat'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Glomus tumor
         </strong>
         – Glomus tumor  (
         <a class="graphic graphic_picture graphicRef51899 graphicRef61115 graphicRef72924" href="/z/d/graphic/51899.html" rel="external">
          picture 37A-C
         </a>
         ) is a rare tumor typically located in the subungual regions of digits. (See
         <a class="local">
          'Glomus tumor'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pigmented lesions
         </strong>
         – Common benign pigmented lesions include acquired and congenital melanocytic nevi and solar lentigines  (
         <a class="graphic graphic_picture graphicRef86484 graphicRef61452" href="/z/d/graphic/86484.html" rel="external">
          picture 39A-B
         </a>
         ). These and other pigmented lesions are discussed in separate topic reviews. (See
         <a class="medical medical_review" href="/z/d/html/4846.html" rel="external">
          "Acquired melanocytic nevi (moles)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4847.html" rel="external">
          "Congenital melanocytic nevi"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5560.html" rel="external">
          "Benign pigmented skin lesions other than melanocytic nevi (moles)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H364334321">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Beth G Goldstein, MD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Banik R, Lubach D. Skin tags: localization and frequencies according to sex and age. Dermatologica 1987; 174:180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boza JC, Trindade EN, Peruzzo J, et al. Skin manifestations of obesity: a comparative study. J Eur Acad Dermatol Venereol 2012; 26:1220.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ragunatha S, Anitha B, Inamadar AC, et al. Cutaneous disorders in 500 diabetic patients attending diabetic clinic. Indian J Dermatol 2011; 56:160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Senel E, Salmanoğlu M, Solmazgül E, Berçik İnal B. Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: a case-control study. J Eur Acad Dermatol Venereol 2011.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah R, Jindal A, Patel N. Acrochordons as a cutaneous sign of metabolic syndrome: a case-control study. Ann Med Health Sci Res 2014; 4:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akpinar F, Dervis E. Association between acrochordons and the components of metabolic syndrome. Eur J Dermatol 2012; 22:106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winton GB, Lewis CW. Dermatoses of pregnancy. J Am Acad Dermatol 1982; 6:977.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peyrin-Biroulet L, Loftus EV Jr, Tremaine WJ, et al. Perianal Crohn's disease findings other than fistulas in a population-based cohort. Inflamm Bowel Dis 2012; 18:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toro JR, Wei MH, Glenn GM, et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet 2008; 45:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuwahara RT, Huber JD, Ray SH. Surgical pearl: forceps method for freezing benign lesion. J Am Acad Dermatol 2000; 43:306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palm MD, Altman JS. Topical hemostatic agents: a review. Dermatol Surg 2008; 34:431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ly I, Romo CG, Gottesman S, et al. Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous Neurofibromas. J Invest Dermatol 2023; 143:1388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hafner C, Vogt T. Seborrheic keratosis. J Dtsch Dermatol Ges 2008; 6:664.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li YH, Chen G, Dong XP, Chen HD. Detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in nongenital seborrhoeic keratosis. Br J Dermatol 2004; 151:1060.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duperret EK, Oh SJ, McNeal A, et al. Activating FGFR3 mutations cause mild hyperplasia in human skin, but are insufficient to drive benign or malignant skin tumors. Cell Cycle 2014; 13:1551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Logié A, Dunois-Lardé C, Rosty C, et al. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Hum Mol Genet 2005; 14:1153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hafner C, Hartmann A, Real FX, et al. Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. J Invest Dermatol 2007; 127:1883.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hafner C, López-Knowles E, Luis NM, et al. Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc Natl Acad Sci U S A 2007; 104:13450.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chu CY, Yang CH, Chiu HC. Inflammation of seborrheic keratoses due to docetaxel treatment. Acta Derm Venereol 2001; 81:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patton T, Zirwas M, Nieland-Fisher N, Jukic D. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat. J Drugs Dermatol 2004; 3:565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cascajo CD, Reichel M, Sánchez JL. Malignant neoplasms associated with seborrheic keratoses. An analysis of 54 cases. Am J Dermatopathol 1996; 18:278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jee H, Lee NR, Ahn SK. Case of seborrheic keratosis with underlying basal cell carcinoma suggesting a collision tumor. J Dermatol 2013; 40:837.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Defazio J, Zalaudek I, Busam KJ, et al. Association between melanocytic neoplasms and seborrheic keratosis: more than a coincidental collision? Dermatol Pract Concept 2012; 2:202a09.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Birnie AJ, Varma S. A dermatoscopically diagnosed collision tumour: malignant melanoma arising within a seborrhoeic keratosis. Clin Exp Dermatol 2008; 33:512.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lim C. Seborrhoeic keratoses with associated lesions: a retrospective analysis of 85 lesions. Australas J Dermatol 2006; 47:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Longo C, Moscarella E, Piana S, et al. Not all lesions with a verrucous surface are seborrheic keratoses. J Am Acad Dermatol 2014; 70:e121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim YK, Kim DY, Lee SJ, et al. Therapeutic efficacy of long-pulsed 755-nm alexandrite laser for seborrheic keratoses. J Eur Acad Dermatol Venereol 2014; 28:1007.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polder KD, Landau JM, Vergilis-Kalner IJ, et al. Laser eradication of pigmented lesions: a review. Dermatol Surg 2011; 37:572.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Culbertson GR. 532-nm diode laser treatment of seborrheic keratoses with color enhancement. Dermatol Surg 2008; 34:525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wood LD, Stucki JK, Hollenbeak CS, Miller JJ. Effectiveness of cryosurgery vs curettage in the treatment of seborrheic keratoses. JAMA Dermatol 2013; 149:108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grimes PE, Arora S, Minus HR, Kenney JA Jr. Dermatosis papulosa nigra. Cutis 1983; 32:385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garcia MS, Azari R, Eisen DB. Treatment of dermatosis papulosa nigra in 10 patients: a comparison trial of electrodesiccation, pulsed dye laser, and curettage. Dermatol Surg 2010; 36:1968.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maghfour J, Ogunleye T. A Systematic Review on the Treatment of Dermatosis Papulosa Nigra. J Drugs Dermatol 2021; 20:467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor SC, Averyhart AN, Heath CR. Postprocedural wound-healing efficacy following removal of dermatosis papulosa nigra lesions in an African American population: a comparison of a skin protectant ointment and a topical antibiotic. J Am Acad Dermatol 2011; 64:S30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wagner G, Back W, Sachse MM. Clear cell acanthoma. J Dtsch Dermatol Ges 2021; 19:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee JH, Kwon HS, Jung HM, et al. Wood's lamp-induced fluorescence of milia. J Am Acad Dermatol 2018; 78:e99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shin D, Seo J, Kim SM, Kim DY. Multiple milia formation induced by dovitinib. J Dermatol 2015; 42:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Connelly T. Eruptive milia and rapid response to topical tretinoin. Arch Dermatol 2008; 144:816.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nambudiri VE, Habib N, Arndt KA, Kane KS. Milia en plaque of the nose: report of a case and successful treatment with topical tretinoin. Pediatrics 2014; 133:e1373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mehrabi D, Leonhardt JM, Brodell RT. Removal of keratinous and pilar cysts with the punch incision technique: analysis of surgical outcomes. Dermatol Surg 2002; 28:673.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee HE, Yang CH, Chen CH, et al. Comparison of the surgical outcomes of punch incision and elliptical excision in treating epidermal inclusion cysts: a prospective, randomized study. Dermatol Surg 2006; 32:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zuber TJ. Minimal excision technique for epidermoid (sebaceous) cysts. Am Fam Physician 2002; 65:1409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klin B, Ashkenazi H. Sebaceous cyst excision with minimal surgery. Am Fam Physician 1990; 41:1746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seidenari S, Pellacani G, Nasti S, et al. Hereditary trichilemmal cysts: a proposal for the assessment of diagnostic clinical criteria. Clin Genet 2013; 84:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hörer S, Marrakchi S, Radner FPW, et al. A Monoallelic Two-Hit Mechanism in PLCD1 Explains the Genetic Pathogenesis of Hereditary Trichilemmal Cyst Formation. J Invest Dermatol 2019; 139:2154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torchia D, Vega J, Schachner LA. Eruptive vellus hair cysts: a systematic review. Am J Clin Dermatol 2012; 13:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saks K, Levitt JO. Tazarotene 0.1 percent cream fares better than erbium:YAG laser or incision and drainage in a patient with eruptive vellus hair cysts. Dermatol Online J 2006; 12:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaya TI, Tataroglu C, Tursen U, Ikizoglu G. Eruptive vellus hair cysts: an effective extraction technique for treatment and diagnosis. J Eur Acad Dermatol Venereol 2006; 20:264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández-Torres R, Del Pozo J, Castiñeiras I, et al. Treatment of multiple eruptive vellus hair cysts with carbon dioxide laser vaporization and manual lateral pressure. Clin Exp Dermatol 2009; 34:e716.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gordon Spratt EA, Kaplan J, Patel RR, et al. Steatocystoma. Dermatol Online J 2013; 19:20721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Covello SP, Smith FJ, Sillevis Smitt JH, et al. Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol 1998; 139:475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bakkour W, Madan V. Carbon dioxide laser perforation and extirpation of steatocystoma multiplex. Dermatol Surg 2014; 40:658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rossi R, Cappugi P, Battini M, et al. CO2 laser therapy in a case of steatocystoma multiplex with prominent nodules on the face and neck. Int J Dermatol 2003; 42:302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choudhary S, Koley S, Salodkar A. A modified surgical technique for steatocystoma multiplex. J Cutan Aesthet Surg 2010; 3:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klebanov N, Lin WM, Artomov M, et al. Use of Targeted Next-Generation Sequencing to Identify Activating Hot Spot Mutations in Cherry Angiomas. JAMA Dermatol 2019; 155:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buslach N, Foulad DP, Saedi N, Mesinkovska NA. Treatment Modalities for Cherry Angiomas: A Systematic Review. Dermatol Surg 2020; 46:1691.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rahmani G, McCarthy P, Bergin D. The diagnostic accuracy of ultrasonography for soft tissue lipomas: a systematic review. Acta Radiol Open 2017; 6:2058460117716704.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chandawarkar RY, Rodriguez P, Roussalis J, Tantri MD. Minimal-scar segmental extraction of lipomas: study of 122 consecutive procedures. Dermatol Surg 2005; 31:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilhelmi BJ, Blackwell SJ, Mancoll JS, Phillips LG. Another indication for liposuction: small facial lipomas. Plast Reconstr Surg 1999; 103:1864.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rotunda AM, Ablon G, Kolodney MS. Lipomas treated with subcutaneous deoxycholate injections. J Am Acad Dermatol 2005; 53:973.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amber KT, Ovadia S, Camacho I. Injection therapy for the management of superficial subcutaneous lipomas. J Clin Aesthet Dermatol 2014; 7:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemaitre M, Chevalier B, Jannin A, et al. Multiple symmetric and multiple familial lipomatosis. Presse Med 2021; 50:104077.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rocha N, Bulger DA, Frontini A, et al. Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression. Elife 2017; 6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Capel E, Vatier C, Cervera P, et al. MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue. J Clin Lipidol 2018; 12:1420.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brea-García B, Cameselle-Teijeiro J, Couto-González I, et al. Madelung's disease: comorbidities, fatty mass distribution, and response to treatment of 22 patients. Aesthetic Plast Surg 2013; 37:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pinto CI, Carvalho PJ, Correia MM. Madelung's Disease: Revision of 59 Surgical Cases. Aesthetic Plast Surg 2017; 41:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keskin D, Ezirmik N, Celik H. Familial multiple lipomatosis. Isr Med Assoc J 2002; 4:1121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansson E, Svensson H, Brorson H. Review of Dercum's disease and proposal of diagnostic criteria, diagnostic methods, classification and management. Orphanet J Rare Dis 2012; 7:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asdourian MS, Shah N, Jacoby TV, et al. Dercum's disease: A retrospective cohort study. J Am Acad Dermatol 2023; 88:738.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansson E, Svensson H, Brorson H. Liposuction may reduce pain in Dercum's disease (adiposis dolorosa). Pain Med 2011; 12:942.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dank JP, Colven R. Protease inhibitor-associated angiolipomatosis. J Am Acad Dermatol 2000; 42:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaneko T, Tokushige H, Kimura N, et al. The treatment of multiple angiolipomas by liposuction surgery. J Dermatol Surg Oncol 1994; 20:690.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanter WR, Wolfort FG. Multiple familial angiolipomatosis: treatment of liposuction. Ann Plast Surg 1988; 20:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gombos Z, Zhang PJ. Glomus tumor. Arch Pathol Lab Med 2008; 132:1448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brems H, Park C, Maertens O, et al. Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association. Cancer Res 2009; 69:7393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stewart DR, Sloan JL, Yao L, et al. Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1. J Med Genet 2010; 47:525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar MG, Emnett RJ, Bayliss SJ, Gutmann DH. Glomus tumors in individuals with neurofibromatosis type 1. J Am Acad Dermatol 2014; 71:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baek HJ, Lee SJ, Cho KH, et al. Subungual tumors: clinicopathologic correlation with US and MR imaging findings. Radiographics 2010; 30:1621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329:1147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hexsel D, Hexsel C, Porto MD, Siega C. Triple combination as adjuvant to cryotherapy in the treatment of solar lentigines: investigator-blinded, randomized clinical trial. J Eur Acad Dermatol Venereol 2015; 29:128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wagner G, Liefeith J, Sachse MM. Clinical appearance, differential diagnoses and therapeutical options of chondrodermatitis nodularis chronica helicis Winkler. J Dtsch Dermatol Ges 2011; 9:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Magro CM, Dyrsen ME. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease. J Am Acad Dermatol 2008; 59:822.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuen-Spiegl M, Ratzinger G, Sepp N, Fritsch P. Chondrodermatitis nodularis chronica helicis - a conservative therapeutic approach by decompression. J Dtsch Dermatol Ges 2011; 9:292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanu A, Koppana R, Snow DG. Management of chondrodermatitis nodularis chronica helicis using a 'doughnut pillow'. J Laryngol Otol 2007; 121:1096.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moncrieff M, Sassoon EM. Effective treatment of chondrodermatitis nodularis chronica helicis using a conservative approach. Br J Dermatol 2004; 150:892.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Timoney N, Davison PM. Management of chondrodermatitis helicis by protective padding: a series of 12 cases and a review of the literature. Br J Plast Surg 2002; 55:387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cox NH, Denham PF. Intralesional triamcinolone for chondrodermatitis nodularis: a follow-up study of 60 patients. Br J Dermatol 2002; 146:712.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gilaberte Y, Frias MP, Pérez-Lorenz JB. Chondrodermatitis nodularis helicis successfully treated with photodynamic therapy. Arch Dermatol 2010; 146:1080.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pellegrino M, Taddeucci P, Mei S, et al. Chondrodermatitis nodularis chronica helicis and photodynamic therapy: a new therapeutic option? Dermatol Ther 2011; 24:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flynn V, Chisholm C, Grimwood R. Topical nitroglycerin: a promising treatment option for chondrodermatitis nodularis helicis. J Am Acad Dermatol 2011; 65:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garrido Colmenero C, Martínez García E, Blasco Morente G, Tercedor Sánchez J. Nitroglycerin patch for the treatment of chondrodermatitis nodularis helicis: a new therapeutic option. Dermatol Ther 2014; 27:278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kechichian E, Jabbour S, Haber R, et al. Management of Chondrodermatitis Nodularis Helicis: A Systematic Review and Treatment Algorithm. Dermatol Surg 2016; 42:1125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lawrence CM. The treatment of chondrodermatitis nodularis with cartilage removal alone. Arch Dermatol 1991; 127:530.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Ru JA, Lohuis PJ, Saleh HA, Vuyk HD. Treatment of chondrodermatitis nodularis with removal of the underlying cartilage alone: retrospective analysis of experience in 37 lesions. J Laryngol Otol 2002; 116:677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor MB. Chondrodermatitis nodularis chronica helicis. Successful treatment with the carbon dioxide laser. J Dermatol Surg Oncol 1991; 17:862.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coldiron BM. The surgical management of chondrodermatitis nodularis chronica helicis. J Dermatol Surg Oncol 1991; 17:902.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kromann N, Høyer H, Reymann F. Chondrodermatitis nodularis chronica helicis treated with curettage and electrocauterization: follow-up of a 15-year material. Acta Derm Venereol 1983; 63:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hussain W, Chalmers RJ. Simplified surgical treatment of chondrodermatitis nodularis by cartilage trimming and sutureless skin closure. Br J Dermatol 2009; 160:116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feldman AL, Manstein CH, Manstein ME, Czulewicz A. Chondrodermatitis nodularis auricularis: a new name for an old disease. Plast Reconstr Surg 2009; 123:25e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jay H, Borek C. Treatment of a venous-lake angioma with intense pulsed light. Lancet 1998; 351:112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freeman DB. Corns and calluses resulting from mechanical hyperkeratosis. Am Fam Physician 2002; 65:2277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gijón-Noguerón G, García-Paya I, Morales-Asencio JM, et al. Short-term effect of scalpel debridement of plantar callosities versus treatment with salicylic acid patches: The EMEDESCA randomized controlled trial. J Dermatol 2017; 44:706.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stephenson J, Farndon L, Concannon M. Analysis of a trial assessing the long-term effectiveness of salicylic acid plasters compared with scalpel debridement in facilitating corn resolution in patients with multiple corns. J Dermatol 2016; 43:662.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5573 Version 52.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3582706" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Skin tags: localization and frequencies according to sex and age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21929550" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Skin manifestations of obesity: a comparative study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21716540" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Cutaneous disorders in 500 diabetic patients attending diabetic clinic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22188364" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24761238" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Acrochordons as a cutaneous sign of metabolic syndrome: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22063265" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Association between acrochordons and the components of metabolic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7047596" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Dermatoses of pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21351216" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Perianal Crohn's disease findings other than fistulas in a population-based cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18234728" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubésyndrome: a new series of 50 families and a review of published reports.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10906655" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Surgical pearl: forceps method for freezing benign lesion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18248471" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Topical hemostatic agents: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37294242" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous Neurofibromas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18801147" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Seborrheic keratosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15541085" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in nongenital seborrhoeic keratosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24626198" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Activating FGFR3 mutations cause mild hyperplasia in human skin, but are insufficient to drive benign or malignant skin tumors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15772091" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17392824" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17673550" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11720193" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Inflammation of seborrheic keratoses due to docetaxel treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15552612" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8806962" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Malignant neoplasms associated with seborrheic keratoses. An analysis of 54 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23957647" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Case of seborrheic keratosis with underlying basal cell carcinoma suggesting a collision tumor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23785597" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Association between melanocytic neoplasms and seborrheic keratosis: more than a coincidental collision?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18462448" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : A dermatoscopically diagnosed collision tumour: malignant melanoma arising within a seborrhoeic keratosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16637806" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Seborrhoeic keratoses with associated lesions: a retrospective analysis of 85 lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24831328" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Not all lesions with a verrucous surface are seborrheic keratoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23909912" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Therapeutic efficacy of long-pulsed 755-nm alexandrite laser for seborrheic keratoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21492309" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Laser eradication of pigmented lesions: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18248487" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : 532-nm diode laser treatment of seborrheic keratoses with color enhancement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23324775" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Effectiveness of cryosurgery vs curettage in the treatment of seborrheic keratoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6226495" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Dermatosis papulosa nigra.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21040130" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Treatment of dermatosis papulosa nigra in 10 patients: a comparison trial of electrodesiccation, pulsed dye laser, and curettage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33852246" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : A Systematic Review on the Treatment of Dermatosis Papulosa Nigra.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21247663" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Postprocedural wound-healing efficacy following removal of dermatosis papulosa nigra lesions in an African American population: a comparison of a skin protectant ointment and a topical antibiotic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32989899" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Clear cell acanthoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29288104" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Wood's lamp-induced fluorescence of milia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25683141" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Multiple milia formation induced by dovitinib.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18559787" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Eruptive milia and rapid response to topical tretinoin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24709934" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Milia en plaque of the nose: report of a case and successful treatment with topical tretinoin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12174056" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Removal of keratinous and pilar cysts with the punch incision technique: analysis of surgical outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16681659" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Comparison of the surgical outcomes of punch incision and elliptical excision in treating epidermal inclusion cysts: a prospective, randomized study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11996426" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Minimal excision technique for epidermoid (sebaceous) cysts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2349906" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Sebaceous cyst excision with minimal surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23061468" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Hereditary trichilemmal cysts: a proposal for the assessment of diagnostic clinical criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31082376" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : A Monoallelic Two-Hit Mechanism in PLCD1 Explains the Genetic Pathogenesis of Hereditary Trichilemmal Cyst Formation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21958358" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Eruptive vellus hair cysts: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17083887" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Tazarotene 0.1 percent cream fares better than erbium:YAG laser or incision and drainage in a patient with eruptive vellus hair cysts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16503884" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Eruptive vellus hair cysts: an effective extraction technique for treatment and diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19663855" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Treatment of multiple eruptive vellus hair cysts with carbon dioxide laser vaporization and manual lateral pressure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24365012" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Steatocystoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9767294" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24852470" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Carbon dioxide laser perforation and extirpation of steatocystoma multiplex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12694500" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : CO2 laser therapy in a case of steatocystoma multiplex with prominent nodules on the face and neck.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20606990" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : A modified surgical technique for steatocystoma multiplex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30601876" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Use of Targeted Next-Generation Sequencing to Identify Activating Hot Spot Mutations in Cherry Angiomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33252464" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Treatment Modalities for Cherry Angiomas: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28717519" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : The diagnostic accuracy of ultrasonography for soft tissue lipomas: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15720097" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Minimal-scar segmental extraction of lipomas: study of 122 consecutive procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10359246" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Another indication for liposuction: small facial lipomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16310057" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Lipomas treated with subcutaneous deoxycholate injections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25013540" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Injection therapy for the management of superficial subcutaneous lipomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34687914" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Multiple symmetric and multiple familial lipomatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28414270" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30158064" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23435503" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Madelung's disease: comorbidities, fatty mass distribution, and response to treatment of 22 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28032179" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Madelung's Disease: Revision of 59 Surgical Cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12516905" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Familial multiple lipomatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22546240" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Review of Dercum's disease and proposal of diagnostic criteria, diagnostic methods, classification and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36228943" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Dercum's disease: A retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21481169" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Liposuction may reduce pain in Dercum's disease (adiposis dolorosa).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10607332" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Protease inhibitor-associated angiolipomatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7930016" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : The treatment of multiple angiolipomas by liposuction surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3358622" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Multiple familial angiolipomatosis: treatment of liposuction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18788860" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Glomus tumor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19738042" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20530151" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24685357" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Glomus tumors in individuals with neurofibromatosis type 1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21071379" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Subungual tumors: clinicopathologic correlation with US and MR imaging findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8377777" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Reduction of solar keratoses by regular sunscreen use.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24684165" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Triple combination as adjuvant to cryotherapy in the treatment of solar lentigines: investigator-blinded, randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21276202" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Clinical appearance, differential diagnoses and therapeutical options of chondrodermatitis nodularis chronica helicis Winkler.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19119098" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21091870" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Chondrodermatitis nodularis chronica helicis - a conservative therapeutic approach by decompression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17524165" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Management of chondrodermatitis nodularis chronica helicis using a 'doughnut pillow'.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15149500" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Effective treatment of chondrodermatitis nodularis chronica helicis using a conservative approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12372366" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Management of chondrodermatitis helicis by protective padding: a series of 12 cases and a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11966717" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Intralesional triamcinolone for chondrodermatitis nodularis: a follow-up study of 60 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20956636" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Chondrodermatitis nodularis helicis successfully treated with photodynamic therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21276169" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Chondrodermatitis nodularis chronica helicis and photodynamic therapy: a new therapeutic option?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21529999" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Topical nitroglycerin: a promising treatment option for chondrodermatitis nodularis helicis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24909052" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Nitroglycerin patch for the treatment of chondrodermatitis nodularis helicis: a new therapeutic option.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27399947" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Management of Chondrodermatitis Nodularis Helicis: A Systematic Review and Treatment Algorithm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2006878" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : The treatment of chondrodermatitis nodularis with cartilage removal alone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12437799" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Treatment of chondrodermatitis nodularis with removal of the underlying cartilage alone: retrospective analysis of experience in 37 lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1757647" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Chondrodermatitis nodularis chronica helicis. Successful treatment with the carbon dioxide laser.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1757652" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : The surgical management of chondrodermatitis nodularis chronica helicis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6191503" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Chondrodermatitis nodularis chronica helicis treated with curettage and electrocauterization: follow-up of a 15-year material.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19014399" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Simplified surgical treatment of chondrodermatitis nodularis by cartilage trimming and sutureless skin closure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19116517" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Chondrodermatitis nodularis auricularis: a new name for an old disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9439501" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Treatment of a venous-lake angioma with intense pulsed light.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12074526" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Corns and calluses resulting from mechanical hyperkeratosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28012190" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Short-term effect of scalpel debridement of plantar callosities versus treatment with salicylic acid patches: The EMEDESCA randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26668108" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Analysis of a trial assessing the long-term effectiveness of salicylic acid plasters compared with scalpel debridement in facilitating corn resolution in patients with multiple corns.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
